Literature DB >> 17909017

Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter.

Ping Zhang1, Kam-Meng Tchou-Wong, Max Costa.   

Abstract

N-myc down-regulated gene 1 (NDRG1/Cap43) is inducible by a variety of environmental stressors, including hypoxia. The present study identified a cis-acting element mediating the transactivation of the NDRG1 gene in murine RAW264.7 macrophage cells treated with hypoxia or deferoxamine, an iron chelator mimicking hypoxia. Through a series of deletions of the promoter of NDRG1 luciferase constructs, a minimal cis-acting element conferring inducibility by hypoxia and deferoxamine was localized to an early growth response 1 (Egr-1) and Sp1 overlapping binding site. Electrophoretic mobility shift assay, antibody supershift assay, and mutations of the Egr-1 binding site confirmed the specific binding of Egr-1 protein to this Egr-1/Sp1 motif. In addition, hypoxia increased the level of Egr-1 protein that correlated with induction of NDRG1 expression at both RNA and protein levels. Transient transfection of the Egr-1 gene into HeLa cells also resulted in up-regulation of the NDRG1 mRNA. The role of Egr-1 was further verified by mutations in the Egr-1 binding site, which reduced promoter inducibility by hypoxia and deferoxamine. Furthermore, the induction of NDRG1 expression by hypoxia and deferoxamine was diminished by RNA interference knockdown of Egr-1 gene expression and in Egr-1-/- mouse embryonic fibroblasts (MEF) compared with Egr-1+/- MEFs. These results showed for the first time that Egr-1 regulates NDRG1 transcription through an overlapping Egr-1/Sp1 binding site that acts as a major site of positive regulation of the NDRG1 promoter by hypoxia signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17909017     DOI: 10.1158/0008-5472.CAN-07-1525

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Transcriptional silencing of N-Myc downstream-regulated gene 1 (NDRG1) in metastatic colon cancer cell line SW620.

Authors:  Qian Li; Hong Chen
Journal:  Clin Exp Metastasis       Date:  2010-12-24       Impact factor: 5.150

Review 2.  Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling.

Authors:  Sharleen V Menezes; Sumit Sahni; Zaklina Kovacevic; Des R Richardson
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

3.  Locus-wide identification of Egr2/Krox20 regulatory targets in myelin genes.

Authors:  Sung-Wook Jang; Rajini Srinivasan; Erin A Jones; Guannan Sun; Sunduz Keles; Courtney Krueger; Li-Wei Chang; Rakesh Nagarajan; John Svaren
Journal:  J Neurochem       Date:  2010-11-04       Impact factor: 5.372

4.  The effect of non-coding DNA variations on P53 and cMYC competitive inhibition at cis-overlapping motifs.

Authors:  Katherine Kin; Xi Chen; Manuel Gonzalez-Garay; Walid D Fakhouri
Journal:  Hum Mol Genet       Date:  2016-02-07       Impact factor: 6.150

Review 5.  Metastasis suppressors in breast cancers: mechanistic insights and clinical potential.

Authors:  Christopher R Bohl; Sitaram Harihar; Warren L Denning; Rahul Sharma; Danny R Welch
Journal:  J Mol Med (Berl)       Date:  2013-12-06       Impact factor: 4.599

6.  Interplay between EGR1 and SP1 is critical for 13-cis retinoic acid-mediated transcriptional repression of angiotensin type 1A receptor.

Authors:  Russell Snyder; Thomas Thekkumkara
Journal:  J Mol Endocrinol       Date:  2013-04-23       Impact factor: 5.098

7.  mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.

Authors:  Markus Weiler; Jonas Blaes; Stefan Pusch; Felix Sahm; Marcus Czabanka; Sebastian Luger; Lukas Bunse; Gergely Solecki; Viktoria Eichwald; Manfred Jugold; Sibylle Hodecker; Matthias Osswald; Christoph Meisner; Thomas Hielscher; Petra Rübmann; Philipp-Niklas Pfenning; Michael Ronellenfitsch; Tore Kempf; Martina Schnölzer; Amir Abdollahi; Florian Lang; Martin Bendszus; Andreas von Deimling; Frank Winkler; Michael Weller; Peter Vajkoczy; Michael Platten; Wolfgang Wick
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-23       Impact factor: 11.205

8.  Expression of hepatocyte growth factor activator inhibitor type 1 on the epithelial cell surface is regulated by hypoxic and oxidative stresses.

Authors:  Wataru Komaki; Tsuyoshi Fukushima; Hiroyuki Tanaka; Hiroshi Itoh; Etsuo Chosa; Hiroaki Kataoka
Journal:  Virchows Arch       Date:  2008-09-04       Impact factor: 4.064

9.  Role of alveolar epithelial early growth response-1 (Egr-1) in CD8+ T cell-mediated lung injury.

Authors:  Chilakamarti V Ramana; Guang-Shing Cheng; Aseem Kumar; Hyung-Joo Kwon; Richard I Enelow
Journal:  Mol Immunol       Date:  2009-09-27       Impact factor: 4.407

10.  Mitogen-activated protein kinase-activated protein kinases 2 and 3 regulate SERCA2a expression and fiber type composition to modulate skeletal muscle and cardiomyocyte function.

Authors:  Madeleine Scharf; Stefan Neef; Robert Freund; Cornelia Geers-Knörr; Mirita Franz-Wachtel; Almuth Brandis; Dorothee Krone; Heike Schneider; Stephanie Groos; Manoj B Menon; Kin-Chow Chang; Theresia Kraft; Joachim D Meissner; Kenneth R Boheler; Lars S Maier; Matthias Gaestel; Renate J Scheibe
Journal:  Mol Cell Biol       Date:  2013-04-22       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.